PLENARY KEYNOTE SESSIONS
SHAPING THE FUTURE OF CANCER PATHWAY-BASED MEDICINE
Comprehensive Cancer Genome Diagnostics in the Era of Targeted Therapy
Jeffrey S. Ross, M.D., Albany Medical College and Foundation Medicine
THE FUTURE OF POINT-OF-CARE FOR INFECTIOUS DISEASE
Clinical Diagnostics – Where Are We Going?
Franklin R. Cockerill, III, M.D., Mayo Medical Laboratories and Mayo Collaborative Services, Inc.
New Developments in Rapid Molecular Testing for Respiratory Viruses
Christine C. Ginocchio, Ph.D., M.T. (ASCP), North Shore-LIJ Health System Laboratories
Short Courses
Roadmap for Accelerating Commercialization of Molecular Diagnostics
Micro- and Nanofluidics in Diagnostics and Life Sciences: Technologies and Applications
Future of Point-of-Care Platforms
2009 PRE-CONFERENCE SYMPOSIA DVDs
The 2009 Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Trends in Cancer Diagnostics, Clinical Adoption of Next Generation Diagnostics, and Molecular Diagnostics for Infectious Disease) was designed to bring together all of the major players in the Molecular Diagnostics arena. We assembled an impressive faculty of speakers from the FDA, leading Medical Centers, Universities and Public Health Laboratories. This meeting showcased advances in technology, research and diagnostic development with special emphasis on clinical adoption and value. In addition, there were two pre-conference Short Courses held in conjunction with the event. CHI recorded and produced the two courses into DVDs.
The DVDs are now available and can be yours today!
Single DVD $295
Site License $995
(SC1) CIRCULATING TUMOR CELLS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS
(SC2) REALITY CHECK ON COMPANION DIAGNOSTICS